Кристи Фанк - Грудь. Руководство пользователя [litres]

M. E. Herman-Giddens et al., “Secondary Sexual Characteristics and Menses in Young Girls Seen in Office Practice: A Study from the Pediatric Research in Office Settings Network,” Pediatrics 99, no. 4 (1997): 505–512.

M. Donovan et al., “Personal Care Products that Contain Estrogens or Xenoestrogens May Increase Breast Cancer Risk,” Medical Hypotheses 68, no. 4 (2007): 756–766.

V. R. Jacobs et al., “Mastitis Nonpuerperalis after Nipple Piercing: Time to Act,” International Journal of Fertility and Women’s Medicine 48, no. 5 (2002): 226–231; J. Martin, “Is Nipple Piercing Compatible with Breastfeeding?” Journal of Human Lactation 20, no. 3 (2004): 319–321.

N. Kluger and V. Koljonen, “Tattoos, Inks, and Cancer,” The Lancet Oncology 13, no. 4 (2012): e161–e168.

K. Lehner et al., “Black Tattoo Inks Are a Source of Problematic Substances Such as Dibutyl Phthalate,” Contact Dermatitis 65 (2011): 231–238.

M. Shermer, “Can You Hear Me Now? The Truth about Cell Phones and Cancer,” Scientific American 303, no. 4 (2010): 98.

B. Leikind, “Do Cell Phones Cause Cancer?” Skeptic 15, no. 4 (2010): 30.

E. Cardis et al., “Brain Tumour Risk in Relation to Mobile Telephone Use: Results of the INTERPHONE International Case-Control Study,” International Journey of Epidemiology 39 (2010): 675; C. Johansen et al., “Cellular Telephones and Cancer: A Nationwide Cohort Study in Denmark,” Journal of the National Cancer Institute 93 (2001): 203; V. G. Khurana et al., “Cell Phones and Brain Tumors: A Review Including the Long-Term Epidemiologic Data,” Surgical Neurology 70 (2009): 205; V. S. Benson et al., “Mobile Phone Use and Risk of Brain Neoplasms and Other Cancers: Prospective Study,” International Journal of Epidemiology 42, no. 3 (2013): 792–802; E. Cardis et al., “Brain Tumour Risk in Relation to Mobile Telephone Use: Results of the INTERPHONE International Case-Control Study,” International Journal of Epidemiology 39, no. 3 (2010): 675.

V. G. Khurana et al., “Cell Phones and Brain Tumors: A Review Including the Long-Term Epidemiologic Data,” Surgical Neurology 70 (2009): 205.

E. R. Schoenfeld et al., “Electromagnetic Fields and Breast Cancer on Long Island: A Case-Control Study,” American Journal of Epidemiology 158, no. 1 (2003): 47–58.

P. K. Verkasalo et al., “Magnetic Fields of High Voltage Power Lines and Risk of Cancer in Finnish Adults: Nationwide Cohort Study,” British Medical Journal 313 (1996): 1047–1051; S. Davis, D. K. Mirick, and R. G. Stevens, “Residential Magnetic Fields and the Risk of Breast Cancer,” American Journal of Epidemiology 155, no. 5 (2002): 446–454.

R. K. Adair, “Constraints on Biological Effects of Weak Extremely-Low-Frequency Electromagnetic Fields,” Physics Review A43 (1991): 1039–1048.

Collaborative Group on Hormonal Factors in Breast Cancer, “Breast Cancer and Hormonal Contraceptives: Collaborative Reanalysis of Individual Data on 53,297 Women with Breast Cancer and 100,239 Women without Breast Cancer from 54 Epidemiological Studies,” The Lancet 347, no. 9017 (1996): 1713–1727.

Jennifer M. Gierisch et al., “Oral Contraceptive Use and Risk of Breast, Cervical, Colorectal, and Endometrial Cancers: A Systematic Review,” Cancer Epidemiology and Prevention Biomarkers 22, no. 11 (2013): 1931–1943.

S. A. Narod et al., “Oral Contraceptives and the Risk of Hereditary Ovarian Cancer: Hereditary Ovarian Cancer Clinical Study Group,” New England Journal of Medicine 339, no. 7 (1998): 424–428.

G. Nikas et al., “Endometrial Pinopodes Indicate a Shift in the Window of Receptivity in IVF Cycles,” Human Reproduction 14 (1999): 787–792.

C. Fei et al., “Fertility Drugs and Young-Onset Breast Cancer: Results from the Two Sister Study,” Journal of the National Cancer Institute 104 (2012): 1021–1027; L. G. Liat et al., “Are Infertility Treatments a Potential Risk Factor for Cancer Development? Perspective of 30 Years of Follow-up,” Gynecological Endocrinology 28, no. 10 (2012): 809–814; L. M. Stewart et al., “In Vitro Fertilization and Breast Cancer: Is There Cause for Concern?” Fertility and Sterility 98, no. 2 (2012): 334–340; A. N. YliKuha et al., “Cancer Morbidity in a Cohort of 9,175 Finnish Women Treated for Infertility,” Human Reproduction 27, no. 4 (2012): 1149–1155; L. A. Brinton et al., “In Vitro Fertilization and Risk of Breast and Gynecologic Cancers: A Retrospective Cohort Study within the Israeli Maccabi Healthcare Services,” Fertility and Sterility 99, no. 5 (2013): 1189–1196.

T. N. Sergentanis et al., “IVF and Breast Cancer: A Systematic Review and Metaanalysis,” Human Reproduction Update 20, no. 1 (2013): 106–123.

A. Q. van den Belt-Dusebout et al., “Ovarian Stimulation for In Vitro Fertilization and Long-Term Risk of Breast Cancer,” Journal of the American Medical Association 316, no. 3 (2016): 300–312.

V. Beral et al., “Breast Cancer and Abortion: Collaborative Reanalysis of Data from 53 Epidemiological Studies, including 83,000 Women with Breast Cancer from 16 Countries,” The Lancet 363, no. 9414 (2004): 1007–1016; K. B. Michels et al., “Induced and Spontaneous Abortion and Incidence of Breast Cancer among Young Women: A Prospective Cohort Study,” Archives of Internal Medicine 167, no. 8 (2007): 814–820; G. K. Reeves et al., “Breast Cancer Risk in Relation to Abortion: Results from the EPIC Study,” International Journal of Cancer 119, no. 7 (2006): 1741–1745; J. Couzin, “Cancer Risk: Review Rules out Abortion – Cancer Link,” Science 299, no. 5612 (2003): 1498.

L. M. Stewart, “In Vitro Fertilization and Breast Cancer: Is There Cause for Concern?” Fertility and Sterility 98, no. 2 (2012): 334–340.

National Cancer Institute, “Abortion, Miscarriage, and Breast Cancer Risk: 2003 Workshop,” обзор за январь 2010, www.cancer.gov/cancertopics/factsheet/Risk/abortion-miscarriage.

V. Beral et al., “Breast Cancer and Abortion: Collaborative Reanalysis of Data from 53 Epidemiological Studies, Including 83,000 Women with Breast Cancer from 16 Countries,” The Lancet 363, no. 9414 (2004): 1007–1016.

D. M. Deapen et al., “The Relationship between Breast Cancer and Augmentation Mammaplasty: An Epidemiologic Study,” Plastic and Reconstructive Surgery 77, no. 3 (1986): 361–368.

D. M. Deapen et al., “Cancer Risk among Los Angeles Women with Cosmetic Breast Implants,” Plastic and Reconstructive Surgery 119, no. 7 (2007): 1987–1992.

E. C. Noels et al., “Breast Implants and the Risk of Breast Cancer: A Meta-analysis of Cohort Studies,” Aesthetic Surgery Journal 35, no. 1 (2015): 55–62.